Top 10 Stocks
Dow Jones U.S. Pharmaceuticals Index
January 4, 2016 - last calculated in January 2017

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from January 4, 2016 (other Top 10 Stocks):


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value INDUSTRY VALUE GROWTH SAFETY COMBINED
1. SciClone (XS, US) Pharmaceuticals
83
80
76
75
2. Merck (XXL, US) ★ Pharmaceuticals
72
2
68
65
3. Heska (XS, US) Pharmaceuticals
69
85
1
66
4. Pfizer (XXL, US) Pharmaceuticals
68
13
75
57
5. Impax (S, US) Pharmaceuticals
67
66
78
50
6. Endocyte (XS, US) Pharmaceuticals
67
47
61
67
7. Sagent (XS, US) Pharmaceuticals
67
35
62
75
8. Depomed (XS, US) Pharmaceuticals
67
98
4
50
9. Medicines Company (S, US) Pharmaceuticals
67
10
28
3
10. Johnson & Johnson (XXL, US) ★ Pharmaceuticals
60
52
25
18

Published: January 4, 2016. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth INDUSTRY VALUE GROWTH SAFETY COMBINED
1. Lannett Company (S, US) Pharmaceuticals
50
100
10
75
2. Depomed (XS, US) Pharmaceuticals
67
98
4
50
3. Pacira Pharma (S, US) Pharmaceuticals
1
98
55
1
4. Akorn (M, US) Pharmaceuticals
25
98
4
1
5. Pernix Therapeutics (XS, US) Pharmaceuticals
20
98
4
1
6. Nektar (S, US) Pharmaceuticals
1
95
36
1
7. Prestige (M, US) Pharmaceuticals
6
93
10
13
8. Supernus Pharma (S, US) Pharmaceuticals
33
90
92
60
9. Heska (XS, US) Pharmaceuticals
69
85
1
66
10. SciClone (XS, US) Pharmaceuticals
83
80
76
75

Published: January 4, 2016. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety INDUSTRY VALUE GROWTH SAFETY COMBINED
1. Vivus (XS, US) Pharmaceuticals
26
71
100
90
2. Bristol-Myers Squibb (XXL, US) ★ Pharmaceuticals
8
51
93
30
3. Supernus Pharma (S, US) Pharmaceuticals
33
90
92
60
4. Impax (S, US) Pharmaceuticals
67
66
78
50
5. Eli Lilly (XXL, US) ★ Pharmaceuticals
16
49
78
50
6. SciClone (XS, US) Pharmaceuticals
83
80
76
75
7. Pfizer (XXL, US) Pharmaceuticals
68
13
75
57
8. Merck (XXL, US) ★ Pharmaceuticals
72
2
68
65
9. Sagent (XS, US) Pharmaceuticals
67
35
62
75
10. Endocyte (XS, US) Pharmaceuticals
67
47
61
67

Published: January 4, 2016. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined INDUSTRY VALUE GROWTH SAFETY COMBINED
1. Vivus (XS, US) Pharmaceuticals
26
71
100
90
2. SciClone (XS, US) Pharmaceuticals
83
80
76
75
3. Sagent (XS, US) Pharmaceuticals
67
35
62
75
4. Lannett Company (S, US) Pharmaceuticals
50
100
10
75
5. Endocyte (XS, US) Pharmaceuticals
67
47
61
67
6. Heska (XS, US) Pharmaceuticals
69
85
1
66
7. Merck (XXL, US) ★ Pharmaceuticals
72
2
68
65
8. Hospira (NA, US) Pharmaceuticals
57
55
57
62
9. Supernus Pharma (S, US) Pharmaceuticals
33
90
92
60
10. Pfizer (XXL, US) Pharmaceuticals
68
13
75
57

Published: January 4, 2016. Top 10s are published weekly by . ()

★ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer then 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stock History D.J. US Pharmaceutical